Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $468,923 | 140 | 56.6% |
| Consulting Fee | $200,885 | 52 | 24.2% |
| Travel and Lodging | $138,354 | 294 | 16.7% |
| Food and Beverage | $20,483 | 625 | 2.5% |
| Education | $323.64 | 8 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Janssen Biotech, Inc. | $229,035 | 258 | $0 (2024) |
| Astellas Pharma US Inc | $184,641 | 194 | $0 (2024) |
| Janssen Scientific Affairs, LLC | $181,455 | 166 | $0 (2024) |
| Ethicon Inc. | $162,628 | 123 | $0 (2024) |
| Ethicon Endo-Surgery Inc. | $31,205 | 29 | $0 (2020) |
| Medical Device Business Services, Inc. | $14,592 | 4 | $0 (2018) |
| PFIZER INC. | $9,766 | 61 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $9,147 | 10 | $0 (2019) |
| Antares Pharma, Inc. | $655.12 | 35 | $0 (2024) |
| Merck Sharp & Dohme LLC | $567.04 | 17 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $97,104 | 187 | Astellas Pharma US Inc ($33,386) |
| 2023 | $64,148 | 133 | Astellas Pharma US Inc ($49,163) |
| 2022 | $115,080 | 138 | Astellas Pharma US Inc ($54,140) |
| 2021 | $70,831 | 68 | Ethicon Inc. ($60,402) |
| 2020 | $54,929 | 78 | Janssen Biotech, Inc. ($23,510) |
| 2019 | $151,859 | 190 | Janssen Biotech, Inc. ($126,805) |
| 2018 | $109,176 | 126 | Janssen Scientific Affairs, LLC ($67,470) |
| 2017 | $165,841 | 199 | Janssen Scientific Affairs, LLC ($112,368) |
All Payment Transactions
1,119 individual payment records from CMS Open Payments — Page 1 of 45
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/26/2024 | Ethicon Inc. | — | Consulting Fee | Cash or cash equivalent | $352.50 | General |
| 12/23/2024 | Ethicon Inc. | — | Travel and Lodging | In-kind items and services | $249.10 | General |
| 12/22/2024 | Dendreon Pharmaceuticals LLC | PROVENGE (Drug) | Food and Beverage | In-kind items and services | $21.45 | General |
| Category: CELLULAR BIOLOGIC TREATMENT FOR PROSTATE CANCER | ||||||
| 12/20/2024 | Ethicon Inc. | — | Travel and Lodging | In-kind items and services | $152.59 | General |
| 12/20/2024 | Ethicon Inc. | — | Travel and Lodging | In-kind items and services | $5.77 | General |
| 12/19/2024 | Ethicon Inc. | — | Travel and Lodging | In-kind items and services | $156.51 | General |
| 12/19/2024 | Ethicon Inc. | — | Food and Beverage | In-kind items and services | $8.55 | General |
| 12/18/2024 | Ethicon Inc. | — | Travel and Lodging | In-kind items and services | $212.07 | General |
| 12/18/2024 | Ethicon Inc. | — | Travel and Lodging | In-kind items and services | $152.59 | General |
| 12/17/2024 | Medtronic, Inc. | INTERSTIM (Device) | Food and Beverage | In-kind items and services | $23.06 | General |
| Category: Sacral Nerve Stimulation | ||||||
| 12/17/2024 | Ethicon Inc. | — | Travel and Lodging | In-kind items and services | $9.26 | General |
| 12/16/2024 | Ethicon Inc. | — | Travel and Lodging | In-kind items and services | $239.24 | General |
| 12/16/2024 | Tolmar, Inc. | ELIGARD (Drug), JATENZO | Food and Beverage | Cash or cash equivalent | $18.07 | General |
| Category: ONCOLOGY | ||||||
| 12/10/2024 | Janssen Biotech, Inc. | ERLEADA (Drug) | Education | In-kind items and services | $74.99 | General |
| Category: Oncology | ||||||
| 12/10/2024 | Sumitomo Pharma America, Inc. | ORGOVYX (Drug) | Food and Beverage | In-kind items and services | $17.27 | General |
| Category: HORMONE THERAPY | ||||||
| 12/09/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | YONSA (Drug) | Food and Beverage | In-kind items and services | $23.99 | General |
| Category: Oncology | ||||||
| 12/06/2024 | Ferring Pharmaceuticals Inc. | ADSTILADRIN (Biological) | Food and Beverage | In-kind items and services | $23.55 | General |
| Category: ONCOLOGY | ||||||
| 12/04/2024 | Ethicon Inc. | — | Travel and Lodging | In-kind items and services | $974.87 | General |
| 12/02/2024 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological) | Food and Beverage | In-kind items and services | $27.33 | General |
| Category: ONCOLOGY | ||||||
| 12/02/2024 | Janssen Biotech, Inc. | ERLEADA (Drug), AKEEGA | Travel and Lodging | In-kind items and services | $5.50 | General |
| Category: Oncology | ||||||
| 11/20/2024 | Astellas Pharma US Inc | Xtandi (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $4,800.00 | General |
| Category: Oncology | ||||||
| 11/20/2024 | Astellas Pharma US Inc | Xtandi (Drug) | Travel and Lodging | Cash or cash equivalent | $432.88 | General |
| Category: Oncology | ||||||
| 11/20/2024 | Astellas Pharma US Inc | Xtandi (Drug) | Travel and Lodging | Cash or cash equivalent | $351.33 | General |
| Category: Oncology | ||||||
| 11/20/2024 | Astellas Pharma US Inc | Xtandi (Drug) | Travel and Lodging | Cash or cash equivalent | $342.04 | General |
| Category: Oncology | ||||||
| 11/20/2024 | Janssen Biotech, Inc. | ERLEADA (Drug), AKEEGA | Travel and Lodging | In-kind items and services | $5.50 | General |
| Category: Oncology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 37 | 2,540 | 6,477 | $523,493 | $237,499 |
| 2022 | 50 | 2,892 | 7,328 | $590,028 | $266,165 |
| 2021 | 47 | 2,939 | 10,471 | $675,891 | $339,065 |
| 2020 | 49 | 2,397 | 13,041 | $579,153 | $274,370 |
All Medicare Procedures & Services
183 procedure records from CMS Medicare Utilization — Page 1 of 8
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 427 | 665 | $95,930 | $60,514 | 63.1% |
| J0897 | Injection, denosumab, 1 mg | Office | 2023 | 11 | 2,460 | $59,640 | $44,774 | 75.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 256 | 349 | $36,560 | $23,238 | 63.6% |
| J9217 | Leuprolide acetate (for depot suspension), 7.5 mg | Office | 2023 | 16 | 162 | $113,400 | $21,752 | 19.2% |
| 52000 | Diagnostic exam of bladder and urethra using an endoscope | Office | 2023 | 84 | 96 | $39,200 | $17,453 | 44.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 89 | 89 | $20,025 | $10,230 | 51.1% |
| 51728 | Complex measurement of pressure of urine flow in bladder with voiding pressure studies | Office | 2023 | 32 | 33 | $18,975 | $9,273 | 48.9% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 32 | 183 | $12,810 | $9,057 | 70.7% |
| 84153 | Psa (prostate specific antigen) measurement, total | Office | 2023 | 185 | 270 | $9,450 | $4,850 | 51.3% |
| 76770 | Complete ultrasound scan behind abdominal cavity | Office | 2023 | 75 | 116 | $16,738 | $4,483 | 26.8% |
| 52356 | Crushing of stone of ureter with insertion of stent using an endoscope | Facility | 2023 | 11 | 12 | $18,000 | $4,106 | 22.8% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2023 | 56 | 63 | $6,300 | $4,027 | 63.9% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 33 | 33 | $5,445 | $3,526 | 64.8% |
| 76775 | Limited ultrasound scan behind abdominal cavity | Office | 2023 | 87 | 166 | $18,848 | $3,192 | 16.9% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 34 | 47 | $4,950 | $3,021 | 61.0% |
| 51798 | Ultrasound measurement of bladder capacity after voiding | Office | 2023 | 196 | 292 | $8,760 | $2,401 | 27.4% |
| 81003 | Automated urinalysis test | Office | 2023 | 493 | 892 | $5,352 | $1,940 | 36.2% |
| 76872 | Ultrasound scan of pelvic region through rectum | Office | 2023 | 13 | 14 | $4,200 | $1,558 | 37.1% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 32 | 34 | $2,380 | $1,531 | 64.3% |
| 84403 | Testosterone (hormone) level, total | Office | 2023 | 42 | 58 | $2,610 | $1,445 | 55.4% |
| 84402 | Testosterone (hormone) level, free | Office | 2023 | 24 | 31 | $1,395 | $752.54 | 53.9% |
| 84270 | Sex hormone binding globulin (protein) level | Office | 2023 | 24 | 31 | $992.00 | $642.19 | 64.7% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 18 | 54 | $1,512 | $580.91 | 38.4% |
| 83970 | Parathormone (parathyroid hormone) level | Office | 2023 | 12 | 14 | $910.00 | $566.30 | 62.2% |
| 74420 | Imaging of urinary tract following injection of a contrast agent | Facility | 2023 | 21 | 29 | $6,525 | $560.74 | 8.6% |
About Dr. William Johnston, MD
Dr. William Johnston, MD is a Urology healthcare provider based in Livonia, Michigan. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/31/2006. The National Provider Identifier (NPI) number assigned to this provider is 1992711030.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. William Johnston, MD has received a total of $828,967 in payments from pharmaceutical and medical device companies, with $97,104 received in 2024. These payments were reported across 1,119 transactions from 58 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($468,923).
As a Medicare-enrolled provider, Johnston has provided services to 10,768 Medicare beneficiaries, totaling 37,317 services with total Medicare billing of $1.1M. Data is available for 4 years (2020–2023), covering 183 distinct procedure/service records.
Practice Information
- Specialty Urology
- Other Specialties Urology
- Location Livonia, MI
- Active Since 07/31/2006
- Last Updated 10/03/2019
- Taxonomy Code 208800000X
- Entity Type Individual
- NPI Number 1992711030
Products in Payments
- Erleada (Drug) $200,669
- Xtandi (Drug) $156,254
- DARZALEX (Biological) $110,350
- ERLEADA (Drug) $92,734
- ETHICON ENDO-SURGERY Curved Intraluminal Stapler (Device) $48,883
- XTANDI (Drug) $30,404
- ZYTIGA (Drug) $15,860
- Monarch Platform (Device) $8,900
- ORGOVYX (Drug) $2,175
- ENDOPATH XCEL Trocar Portfolio (Device) $1,906
- LAPRA-TY Suture Clip (Device) $1,583
- N/A (Device) $972.00
- KEYTRUDA (Biological) $536.00
- Monarch (Device) $485.62
- FIRMAGON (Drug) $423.52
- VICRYL (Device) $403.89
- NOCDURNA (Drug) $365.85
- ELIGARD (Drug) $338.49
- GEMTESA (Drug) $324.95
- HARMONIC Product Family (Device) $310.48
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Urology Doctors in Livonia
Dr. John Harb, Md, MD
Urology — Payments: $22,676
Dr. Jeffrey Schock, D.o, D.O
Urology — Payments: $13,939
Dr. Gregory Mcintosh, D.o, D.O
Urology — Payments: $11,045
Dr. Michael Hoff, D.o, D.O
Urology — Payments: $8,122
Dr. Benjamin Johnson, M.d, M.D
Urology — Payments: $6,026
Dr. Michael Macdonald, M.d, M.D
Urology — Payments: $661.74